Dovasan Tablets (Dovesil Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500~1000mg daily 2. Venous disease: 750mg daily for 1~3 weeks, followed by 500mg daily. Take after meals with plenty of fluids. The dose may be adjusted as appropriate according to age and symptoms.

This medication should not be used by patients who are hypersensitive to this medication or its components. This medication contains lactose, so patients with hereditary issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication. Patients with impaired renal function should use caution, and particularly those with end-stage renal disease requiring dialysis may need to reduce the dosage. Patients with liver dysfunction should also exercise caution when using this medication, and if liver enzymes significantly increase, the benefits of treatment should be reevaluated. This medication contains sodium metabisulfite, which can cause severe allergic reactions or asthmatic episodes in individuals who are allergic to sulfites, so caution is required. Common side effects such as headaches, abdominal pain, nausea, diarrhea, vomiting, arthralgia, and myalgia may occur while taking this medication. Additionally, very rarely, severe hypersensitivity reactions such as blood disorders or anaphylaxis may occur, so if symptoms such as fever, skin rash, and difficulty breathing arise, the medication should be discontinued immediately and a doctor should be consulted. This medication can rarely cause agranulocytosis, and if there are symptoms of high fever or infection, a doctor should be notified immediately. The effects on driving or operating machinery are not clearly established, so caution is advised. Pregnant or nursing women are advised to avoid the use of this medication, and particularly while nursing, it is recommended to discontinue either the medication or breastfeeding. Safety in children has not been sufficiently studied; therefore, it should be administered to children with caution. There are no special precautions for elderly patients over 65 years; however, caution may be necessary depending on individual conditions. This medication may affect the measurement of creatinine levels in blood tests, so it is advisable to collect samples before treatment. There are no specific reported symptoms in case of overdose, but general emergency measures should be taken.

• Agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• itching
• urticaria
• facial swelling
• anaphylactic reaction
• headache

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the medication.

Appearance

White round tablet

Package unit

30 tablets/bottle, 90 tablets/bottle